Brain Tumor Image Registration and Segmentation for Radiotherapy Response

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for tracking brain metastases after radiotherapy are manual, time-consuming, and prone to human error, lacking a comprehensive solution for automatically tracking and quantifying tumor responses in brain metastases across multiple imaging sessions.

Innovation Solution

A deep learning-based system, METRO, performs image registration, segmentation, and tracking of brain metastases using convolutional neural networks to generate longitudinal maps of tumor volumes, aligning images with treatment plans, and providing dose metrics, thereby automating the process of monitoring tumor responses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If manual methods are used to track brain metastases after radiotherapy, then clinical expertise and judgment can be applied, but the process is time-consuming and prone to human error

Engineering Contradiction:
Improveaccuracy of tumor trackingVSAvoidtime required for manual tracking
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system enables automated self-tracking of brain metastases by using machine learning models to automatically segment tumors, register images, and calculate volumetric changes without requiring manual clinical intervention for each measurement step

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces manual mechanical measurement processes with automated computational systems, using deep learning algorithms to perform image segmentation, registration, and volumetric calculation that were previously done manually by clinicians

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If manual tracking methods are used, then flexibility in clinical judgment is maintained, but measurement precision and consistency are reduced

Engineering Contradiction:
Improveprecision of tumor volume measurementVSAvoidcomplexity of automated tracking system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces manual measurement processes with automated computational systems, using deep learning algorithms to perform image segmentation, registration, and volumetric calculation that were previously done manually by clinicians

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system transforms complex medical imaging data into standardized volumetric parameters through automated processing, changing the state of raw image data into quantifiable tumor volume metrics that can be consistently compared over time

Inventive Principle:
Principle #35Parameter changes

3Productivity

If comprehensive automated tracking is implemented, then time efficiency and measurement consistency are improved, but system complexity increases

Engineering Contradiction:
Improveefficiency of tumor monitoringVSAvoidcomplexity of image processing system
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system divides the complex task of tumor tracking into distinct modular components: image registration module, tumor segmentation module, volumetric calculation module, and reporting module, allowing each to be optimized independently

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The automated tracking system is designed to handle multiple imaging modalities and tumor types through a unified platform, making the complex system broadly applicable across different clinical scenarios

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250371705A1Determining tumor responsiveness to radiotherapies from biomedical images
Publication Date: 2025.12.04 MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASES
  • US20250371705A1 patent drawing
  • US20250371705A1 patent drawing
  • US20250371705A1 patent drawing

AI summary

Presented herein are systems and methods of determining tumor responses in brains from administering radiotherapy. A computing system can: identify a plurality of biomedical images of a brain of a subject; perform an image registration on a first biomedical image with a second biomedical image to determine a plurality of translation parameters; generate a third biomedical image using the second biomedical image in accordance with the plurality of translation parameters, detect using an image segmentation model, (i) a first segment identifying a first region within the third biomedical image and (ii) a second segment identifying a second region within the second biomedical image; and determine a metric indicating a degree of responsiveness of a tumor in the subject to the administration of the radiotherapy to the brain, based on the first segment and the second segment.